Kestis Vaitkus

459 total citations
22 papers, 343 citations indexed

About

Kestis Vaitkus is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kestis Vaitkus has authored 22 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 21 papers in Molecular Biology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kestis Vaitkus's work include Hemoglobinopathies and Related Disorders (22 papers), Epigenetics and DNA Methylation (21 papers) and Cancer-related gene regulation (8 papers). Kestis Vaitkus is often cited by papers focused on Hemoglobinopathies and Related Disorders (22 papers), Epigenetics and DNA Methylation (21 papers) and Cancer-related gene regulation (8 papers). Kestis Vaitkus collaborates with scholars based in United States. Kestis Vaitkus's co-authors include Donald Lavelle, Joseph DeSimone, Vinzon Ibañez, Mahipal Singh, Maria Armila Ruiz, Yogen Saunthararajah, Angela Rivers, Nadim Mahmud, Tatiana Kouznetsova and Ramasamy Jagadeeswaran and has published in prestigious journals such as Blood, PLoS ONE and Journal of Translational Medicine.

In The Last Decade

Kestis Vaitkus

21 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kestis Vaitkus United States 12 269 208 113 60 28 22 343
Maria Suciu United Kingdom 4 236 0.9× 180 0.9× 77 0.7× 144 2.4× 47 1.7× 6 388
Rosalba Di Marzo Italy 10 146 0.5× 251 1.2× 167 1.5× 66 1.1× 34 1.2× 23 365
Kalin Mayberry United States 7 160 0.6× 107 0.5× 46 0.4× 24 0.4× 40 1.4× 16 227
Alireza Ghamari United States 5 152 0.6× 66 0.3× 57 0.5× 28 0.5× 34 1.2× 8 251
Anne Boland France 3 207 0.8× 338 1.6× 209 1.8× 128 2.1× 47 1.7× 5 433
G. V. Sciarratta Italy 11 108 0.4× 292 1.4× 193 1.7× 88 1.5× 68 2.4× 27 387
Wattanan Makarasara Thailand 5 69 0.3× 273 1.3× 224 2.0× 87 1.4× 40 1.4× 8 318
AE Kulozik United Kingdom 9 149 0.6× 465 2.2× 367 3.2× 100 1.7× 43 1.5× 12 566
Manoussos N. Papadakis Greece 10 105 0.4× 203 1.0× 139 1.2× 76 1.3× 18 0.6× 22 301
Elmutaz Shaikho Elhaj Mohammed United States 6 57 0.2× 71 0.3× 57 0.5× 30 0.5× 9 0.3× 6 135

Countries citing papers authored by Kestis Vaitkus

Since Specialization
Citations

This map shows the geographic impact of Kestis Vaitkus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kestis Vaitkus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kestis Vaitkus more than expected).

Fields of papers citing papers by Kestis Vaitkus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kestis Vaitkus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kestis Vaitkus. The network helps show where Kestis Vaitkus may publish in the future.

Co-authorship network of co-authors of Kestis Vaitkus

This figure shows the co-authorship network connecting the top 25 collaborators of Kestis Vaitkus. A scholar is included among the top collaborators of Kestis Vaitkus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kestis Vaitkus. Kestis Vaitkus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibañez, Vinzon, Kestis Vaitkus, Maria Armila Ruiz, et al.. (2023). Effect of the LSD1 inhibitor RN-1 on γ-globin and global gene expression during erythroid differentiation in baboons (Papio anubis). PLoS ONE. 18(12). e0289860–e0289860.
2.
Ibañez, Vinzon, Kestis Vaitkus, Xu Zhang, et al.. (2023). Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF. Blood Advances. 7(15). 3891–3902. 5 indexed citations
3.
Rivers, Angela, Kestis Vaitkus, Ramasamy Jagadeeswaran, et al.. (2018). Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons. Experimental Hematology. 67. 60–64.e2. 18 indexed citations
4.
Rivers, Angela, Kestis Vaitkus, Ramasamy Jagadeeswaran, et al.. (2017). Oral Administration of the LSD1 Inhibitor OG-S1335 Increases Fetal Hemoglobin in Humanized Transgenic Sickle Cell Disease Mice and in Baboons. Blood. 130. 356–356. 1 indexed citations
5.
Ruiz, Maria Armila, Angela Rivers, Vinzon Ibañez, et al.. (2015). Hydroxymethylcytosine and demethylation of theγ-globingene promoter during erythroid differentiation. Epigenetics. 10(5). 397–407. 23 indexed citations
6.
Jagadeeswaran, Ramasamy, Vinzon Ibañez, Maria Armila Ruiz, et al.. (2015). Investigation of Two Combination HbF Induction Regimens, RN-1 and Hydroxyurea Versus RN-1 and Decitabine, in a Humanized Sickle Cell Mouse Model. Blood. 126(23). 3386–3386. 3 indexed citations
7.
Rivers, Angela, Kestis Vaitkus, Maria Armila Ruiz, et al.. (2015). RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model. Experimental Hematology. 43(7). 546–553.e3. 37 indexed citations
8.
Rivers, Angela, Kestis Vaitkus, Maria Armila Ruiz, et al.. (2014). RN-1, a Potent and Selective LSD1 Inhibitor, Induces High Levels of Fetal Hemoglobin (HbF) in Anemic Baboons (P. anubis). Blood. 124(21). 336–336. 1 indexed citations
9.
Lavelle, Donald, Kestis Vaitkus, Yonghua Ling, et al.. (2011). Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine. Blood. 119(5). 1240–1247. 72 indexed citations
10.
Akpan, Imo J., et al.. (2010). Decitabine increases fetal hemoglobin in Papio anubis by increasing γ-globin gene transcription. Experimental Hematology. 38(11). 989–993.e1. 21 indexed citations
11.
Ibañez, Vinzon, Kestis Vaitkus, Maria Armila Ruiz, et al.. (2010). siDNMT1 increases γ-globin expression in chemical inducer of dimerization (CID)−dependent mouse βYAC bone marrow cells and in baboon erythroid progenitor cell cultures. Experimental Hematology. 39(1). 26–36.e1. 22 indexed citations
12.
Lavelle, Donald, Yogen Saunthararajah, Kestis Vaitkus, et al.. (2010). S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis). Journal of Translational Medicine. 8(1). 92–92. 23 indexed citations
13.
Singh, Mahipal, Kestis Vaitkus, Vinzon Ibañez, et al.. (2009). Transcriptional activation of the γ-globin gene in baboons treated with decitabine and in cultured erythroid progenitor cells involves different mechanisms. Experimental Hematology. 37(10). 1131–1142. 22 indexed citations
14.
Ibañez, Vinzon, et al.. (2008). The Role of DNA Damage/Stress Response Pathways in the Mechanism of Action of Decitabine. Blood. 112(11). 490–490. 1 indexed citations
15.
16.
Lavelle, Donald, Kestis Vaitkus, Sanjeev Redkar, et al.. (2007). Oral decitabine reactivates expression of the methylated γ‐globin gene in Papio anubis. American Journal of Hematology. 82(11). 981–985. 28 indexed citations
17.
Lavelle, Donald, et al.. (2006). Developmental changes in DNA methylation and covalent histone modifications of chromatin associated with the ε-, γ-, and β-globin gene promoters in Papio anubis. Blood Cells Molecules and Diseases. 36(2). 269–278. 19 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Suciu Breakdown of academic impact, for papers by Rosalba Di Marzo Breakdown of academic impact, for papers by Kalin Mayberry Breakdown of academic impact, for papers by Alireza Ghamari Breakdown of academic impact, for papers by Anne Boland Breakdown of academic impact, for papers by G. V. Sciarratta Breakdown of academic impact, for papers by Wattanan Makarasara Breakdown of academic impact, for papers by AE Kulozik Breakdown of academic impact, for papers by Manoussos N. Papadakis Breakdown of academic impact, for papers by Elmutaz Shaikho Elhaj Mohammed
Rankless by CCL
2026